Developer docs
API playgroundTry for free, no card

Search company profiles

Merz North America

Full company profile

uuid000croq

Namestring
Merz North America
Legal namestring
Merz North America, Inc.
Websiteurl
merzusa.com
Company typeenum
Private
Founded yearint
1908
Descriptiontext

Merz North America, Inc. is the US-based commercial subsidiary of the German pharmaceutical group Merz Pharma GmbH & Co. KGaA, headquartered in Raleigh, North Carolina. The company participates in research, development, and distribution of medical products in the United States, organized into two operating divisions: Merz Aesthetics, which provides facial aesthetics and cosmetic medical products (including applications such as wrinkle reduction), and Merz Therapeutics, which delivers therapeutic medical products. Product information is restricted to US residents, and the entity serves the North American (US) market exclusively.

The company distributes its products through healthcare providers, dermatology clinics, and medical spas, operating dedicated web properties for each division (us.merzaesthetics.com and merztherapeutics.com/us). Pricing is not publicly disclosed and product information is intended for US residents only, consistent with a B2B specialty pharma distribution model. The firm maintains an internal Scientific Affairs function led by Dr. Peter A. Kreymerman, supporting clinical evidence and provider education.

Merz North America is a private corporation with 501-1000 employees, leveraging the parent company's trademark and brand (founded 1908) within the US market. The two-division structure separates aesthetic and therapeutic product lines while consolidating North American commercial operations under a single legal entity. No detailed financial disclosures, funding events, M&A activity, or strategic transactions are available in the source data.

Short descriptiontext

Merz North America is the US subsidiary of Merz Pharma GmbH & Co. KGaA, distributing aesthetic and therapeutic medical products through dermatology clinics, medical spas, and healthcare providers across the United States.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersRaleigh, United States
HQ citystring
Raleigh
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
aesthetic medical products, dermatological therapeutics, facial aesthetics treatments, medical spa supplies, pharmaceutical distribution
Industry1 code
1Dermatology & Aesthetics Pharmaceuticals
CodeHLAIAAAKPrimaryYes
NAICS code1 code
  • Pharmaceutical Preparation Manufacturing325412
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Medical Aesthetics and Therapeutics
Social media profiles1 record
Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Merz North America, Inc. is the U.S. subsidiary of German pharmaceutical conglomerate Merz Pharma GmbH & Co. KGaA, operating two business divisions. Merz Aesthetics provides facial aesthetics and cosmetic products, while Merz Therapeutics delivers medical therapeutics for neurological and other health conditions. The company develops, manufactures, and distributes prescription-based aesthetic and therapeutic medical products to healthcare providers across the United States.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Merz North America operates as a unified company with two main business divisions: Merz Aesthetics and Merz Therapeutics. Merz Aesthetics focuses on the facial aesthetics and cosmetic procedures market, while Merz Therapeutics provides medical therapeutic products. The company serves the US market exclusively, with product information intended for US residents only.

Product and service2 records
1Merz Aesthetics
CategoryAesthetic Medicine
Description

Merz Aesthetics is the facial aesthetics division that develops, manufactures, and commercializes injectable and topical aesthetic products for use by dermatologists, plastic surgeons, and medical spas in cosmetic facial treatments.

2Merz Therapeutics
CategoryPharmaceutical Therapeutics
Description

Merz Therapeutics is the prescription therapeutics division that develops and markets pharmaceutical products for the treatment of neurological disorders and related medical conditions, distributed to healthcare professionals and institutions across the U.S.

Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers7 records
1Galderma
TypeDirect peer
Description

Galderma is a pure-play dermatology and aesthetics company with leading filler franchises (Restylane, Sculptra) and growing presence in neurotoxins. It is a direct peer to Merz North America because it competes in the same US facial aesthetics provider channel across injectables and skin-care adjacencies.

2Hugel America
TypeDirect peer
Description

Hugel is a Korean aesthetics and dermatology company with a US presence marketing botulinum toxin (Letybo) and dermal fillers. It competes in the same US aesthetics injector market as Merz Aesthetics, particularly in dermatology and medical-spa accounts.

3Allergan Aesthetics (AbbVie)
TypeDirect peer
Description

Allergan Aesthetics, an AbbVie division, is the global market leader in facial aesthetics with Botox, Juvederm, and CoolSculpting. It is the most direct comparable because it competes head-to-head with Merz Aesthetics in injectable neurotoxins and dermal fillers targeting the same US dermatology and medical-spa channel.

4Revance Therapeutics
TypeDirect peer
Description

Revance is a US aesthetics-focused biotechnology company that launched Daxxify, a longer-duration neuromodulator, and the RHA dermal filler line. It directly competes with Merz Aesthetics in the same US specialty aesthetics channel with overlapping neurotoxin and filler offerings.

5Bausch Health (Solta Medical / aesthetics)
TypeBroad incumbent
Description

Bausch Health is a broad specialty pharmaceutical and medical-aesthetics company owning Solta Medical (Thermage, Clear+Brilliant) and other aesthetics devices. It is a broad incumbent comparator because it overlaps with Merz North America's aesthetics channel across energy-based devices and adjacent consumer categories.

6Evolus
TypeDirect peer
Description

Evolus is a US aesthetics specialty company commercializing Jeuveau, a botulinum toxin type A, targeting the same consumer/medical-spa channel as Merz Aesthetics. It is a direct peer as a focused aesthetics neuromodulator competitor serving overlapping providers.

7Ipsen
TypeDirect peer
Description

Ipsen is a global pharmaceutical company that markets Dysport (abobotulinumtoxinA) in the US through partnerships. It is a direct peer to Merz North America's aesthetics franchise because both companies field neurotoxin franchises competing for the same US specialty provider accounts.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Merz North America

Medical Aesthetics and Therapeuticsmerzusa.com

Merz North America is the US subsidiary of Merz Pharma GmbH & Co. KGaA, distributing aesthetic and therapeutic medical products through dermatology clinics, medical spas, and healthcare providers across the United States.

What Merz North America does

Merz North America, Inc. is the US-based commercial subsidiary of the German pharmaceutical group Merz Pharma GmbH & Co. KGaA, headquartered in Raleigh, North Carolina. The company participates in research, development, and distribution of medical products in the United States, organized into two operating divisions: Merz Aesthetics, which provides facial aesthetics and cosmetic medical products (including applications such as wrinkle reduction), and Merz Therapeutics, which delivers therapeutic medical products. Product information is restricted to US residents, and the entity serves the North American (US) market exclusively.

The company distributes its products through healthcare providers, dermatology clinics, and medical spas, operating dedicated web properties for each division (us.merzaesthetics.com and merztherapeutics.com/us). Pricing is not publicly disclosed and product information is intended for US residents only, consistent with a B2B specialty pharma distribution model. The firm maintains an internal Scientific Affairs function led by Dr. Peter A. Kreymerman, supporting clinical evidence and provider education.

Merz North America is a private corporation with 501-1000 employees, leveraging the parent company's trademark and brand (founded 1908) within the US market. The two-division structure separates aesthetic and therapeutic product lines while consolidating North American commercial operations under a single legal entity. No detailed financial disclosures, funding events, M&A activity, or strategic transactions are available in the source data.

Merz North America firmographics

Firmographics
Name
Merz North America
Legal name
Merz North America, Inc.
Website
https://merzusa.com
Company type
Private
Founded year
1908
Operating status
Operating
Headcount range
501–1,000 employees
Short description
Merz North America is the US subsidiary of Merz Pharma GmbH & Co. KGaA, distributing aesthetic and therapeutic medical products through dermatology clinics, medical spas, and healthcare providers across the United States.
Ownership category
akta.pro rank

Merz North America industry classification

Industry
Product category
Medical Aesthetics and Therapeutics
NAICS
Pharmaceutical Preparation Manufacturing (325412)
SIC
Pharmaceutical Preparations (2834)
akta.pro primary industry
Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK)

Keywords

  • Aesthetic medical products
  • Dermatological therapeutics
  • Facial aesthetics treatments
  • Medical spa supplies
  • Pharmaceutical distribution

Where Merz North America is headquartered

Location

Headquarters

HQ city
Raleigh
HQ country
United States
HQ region
North America

Markets served

Merz North America business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain

Merz North America product offering

Product offering

Core offering

Merz North America, Inc. is the U.S. subsidiary of German pharmaceutical conglomerate Merz Pharma GmbH & Co. KGaA, operating two business divisions. Merz Aesthetics provides facial aesthetics and cosmetic products, while Merz Therapeutics delivers medical therapeutics for neurological and other health conditions. The company develops, manufactures, and distributes prescription-based aesthetic and therapeutic medical products to healthcare providers across the United States.

Product overview

Merz North America operates as a unified company with two main business divisions: Merz Aesthetics and Merz Therapeutics. Merz Aesthetics focuses on the facial aesthetics and cosmetic procedures market, while Merz Therapeutics provides medical therapeutic products. The company serves the US market exclusively, with product information intended for US residents only.

Differentiator

Problem solved

Functional benefit

Products and services

  • Merz Aesthetics Merz Aesthetics is the facial aesthetics division that develops, manufactures, and commercializes injectable and topical aesthetic products for use by dermatologists, plastic surgeons, and medical spas in cosmetic facial treatments.
  • Merz Therapeutics Merz Therapeutics is the prescription therapeutics division that develops and markets pharmaceutical products for the treatment of neurological disorders and related medical conditions, distributed to healthcare professionals and institutions across the U.S.

Companies that use Merz North America

Customer profile

Segments1 record

Ideal customer profiles2 records

Merz North America technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Merz North America partnerships and signals

Strategic signal

Recent moves3 records

Expansion highlights3 records

Merz North America competitors and assessment

Company assessment

Direct peers

  • Galderma: Galderma is a pure-play dermatology and aesthetics company with leading filler franchises (Restylane, Sculptra) and growing presence in neurotoxins. It is a direct peer to Merz North America because it competes in the same US facial aesthetics provider channel across injectables and skin-care adjacencies.
  • Hugel America: Hugel is a Korean aesthetics and dermatology company with a US presence marketing botulinum toxin (Letybo) and dermal fillers. It competes in the same US aesthetics injector market as Merz Aesthetics, particularly in dermatology and medical-spa accounts.
  • Allergan Aesthetics (AbbVie): Allergan Aesthetics, an AbbVie division, is the global market leader in facial aesthetics with Botox, Juvederm, and CoolSculpting. It is the most direct comparable because it competes head-to-head with Merz Aesthetics in injectable neurotoxins and dermal fillers targeting the same US dermatology and medical-spa channel.
  • Revance Therapeutics: Revance is a US aesthetics-focused biotechnology company that launched Daxxify, a longer-duration neuromodulator, and the RHA dermal filler line. It directly competes with Merz Aesthetics in the same US specialty aesthetics channel with overlapping neurotoxin and filler offerings.
  • Evolus: Evolus is a US aesthetics specialty company commercializing Jeuveau, a botulinum toxin type A, targeting the same consumer/medical-spa channel as Merz Aesthetics. It is a direct peer as a focused aesthetics neuromodulator competitor serving overlapping providers.
  • Ipsen: Ipsen is a global pharmaceutical company that markets Dysport (abobotulinumtoxinA) in the US through partnerships. It is a direct peer to Merz North America's aesthetics franchise because both companies field neurotoxin franchises competing for the same US specialty provider accounts.

Broad incumbents

  • Bausch Health (Solta Medical / aesthetics): Bausch Health is a broad specialty pharmaceutical and medical-aesthetics company owning Solta Medical (Thermage, Clear+Brilliant) and other aesthetics devices. It is a broad incumbent comparator because it overlaps with Merz North America's aesthetics channel across energy-based devices and adjacent consumer categories.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks4 records

Key highlights5 records

Customer concentration

Merz North America social profiles

Digital presence

Merz North America financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Merz North America leadership team

Management profile

Number of profiles

Profiles1 record

Merz North America funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Merz North America M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Merz North America

What does Merz North America do?

Merz North America, Inc. is the U.S. subsidiary of German pharmaceutical conglomerate Merz Pharma GmbH & Co. KGaA, operating two business divisions. Merz Aesthetics provides facial aesthetics and cosmetic products, while Merz Therapeutics delivers medical therapeutics for neurological and other health conditions. The company develops, manufactures, and distributes prescription-based aesthetic and therapeutic medical products to healthcare providers across the United States.

Is Merz North America a public or private company?

Merz North America is a private company. It is classified as corporate owned and is currently operating.

When was Merz North America founded?

Merz North America was founded in 1908. It employs 501 to 1,000 people.

Where is Merz North America based?

Merz North America is headquartered in Raleigh, United States, in the North America region.

Who are Merz North America's main competitors?

Direct peers on record are Galderma, Hugel America, Allergan Aesthetics (AbbVie), Revance Therapeutics, Evolus and Ipsen. Bausch Health (Solta Medical / aesthetics) is listed as a broad incumbent.

Does Merz North America have an API?

No public API is recorded for Merz North America.

What industry is Merz North America in?

Merz North America's product category is Medical Aesthetics and Therapeutics. Its primary akta.pro industry code is HLAIAAAK, Dermatology & Aesthetics Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
MDPICalcium Hydroxyapatite Biostimulators: A Comparative Study of Biological Response and Particle MorphologyResearchers at Protocoll Clinique (Vitória, Brazil) and Nucleo Vitro (Porto Alegre, Brazil) conducted a comparative in vitro study evaluating two calcium hydroxyapatite-based dermal biostimulators—Radiesse (Sample R, manufactured by Merz North America) and Stiim (Sample S, manufactured by CG Bio Co., Ltd.)—on human dermal fibroblast cultures. Both materials demonstrated biocompatibility, increasing fibroblast metabolic activity and collagen/elastin gene expression relative to controls, with Sample S showing significantly higher responses at 48 and 72 hours. Scanning electron microscopy revealed both products contain spherical CaHA microspheres but exhibit distinct surface microtopographies, which the authors suggest may contribute to the observed differences in biological response.openPR.comEurope Anti-Wrinkle Skincare Device Market Growth Boosted by Aging Population & Beauty Tech | Major Players: Solawave, NuFACE, CurrentBody, ES Beauty Solutions, Merz North America, Inc., Project E BeaThe global anti-wrinkle skincare device market is projected to grow from US$10.96 billion in 2024 to US$23.60 billion by 2033, a CAGR of 8.8%. Growth is driven by an aging population and demand for at-home solutions, with recent FDA clearances and new product launches in 2025.PR NewswireOutlook on the Scar Treatment Global Market to 2030: Players Include Smith & Nephew, Merz North America, LUMENIS, Enaltus, Sonoma Pharmaceuticals and Molnlycke Health CareResearchAndMarkets.com published a market report projecting the global scar treatment market to reach USD 54.9 billion by 2030, expanding at a 9.9% CAGR from 2023 to 2030, with topical products dominating in 2022 and laser products expected to witness the highest growth over the forecast period.PR NewswireCytophil and Merz Settle Patent DisputeMerz North America, Inc. and Cytophil, Inc. have reached a settlement resolving all patent litigation between them, with Merz granting Cytophil's Renu® Voice product a royalty-bearing license to U.S. Patent No. 6,537,574 for the remaining ten months of the patent. As part of the agreement, both companies have agreed to immediate dismissal of all pending litigation and have released each other from all existing legal claims. Cytophil's RegenScientific unit has been selling the FDA-cleared Renu® Voice, a resorbable implant for vocal fold augmentation, in the United States for several years.PR NewswireMedshift Announces Five Year Partnership with Merz North AmericaMedShift announced a five-year strategic partnership with Merz North America to distribute and expand access to Merz's Cellfina, an FDA-cleared device for long-lasting reversal of cellulose. As part of the agreement, MedShift will launch a new brand called Effront\u00e9 to make the Cellfina technology more accessible to women, building on its history of investing over $10 million since 2015 in women\u2019s health solutions. The partnership combines both companies\u2019 focus on innovative product development for physicians and improving patient outcomes.PR NewswireeRelevance Expands Executive Leadership Team with Senior Sales and Business Development AppointmentseRelevance Corporation appointed Andy Acaru as vice president of field sales and John Nippler as vice president of business development to drive growth in the aesthetic healthcare market. These hires aim to expand strategic partnerships and acquire large healthcare practices, leveraging the executives' prior experience at firms such as Cynosure and Merz North America.FinSMEsMerz North America buys ON Light SciencesMerz North America acquired ON Light Sciences, a medical device company developing technologies to enhance laser-based dermatologic procedures. The deal amount was not disclosed. ON Light Sciences' product, the DeScribe® Transparent PFD patch, is FDA 510(k) cleared and CE marked for tattoo removal.PR NewswireEpoxy, Inc. to Build Epoxy Application for Merz North AmericaEpoxy Inc. has signed an agreement with Merz North America, Inc. to develop the 'Merz Powered by Epoxy' platform, marking the company's expansion into the healthcare sector. The mobile application platform will digitalize the healthcare industry and provide Merz customers with a hands-on experience prior to rollout. Dave Gasparine of Epoxy noted that the partnership represents one of the company's most exciting projects to date, with plans to expand corporate training professionals to support the new platform.GlobeNewswireAngioDynamics and Merz North America Establish Multi-Year Relationship to Market Asclera for Vein PatientsAngioDynamics and Merz North America signed an agreement for AngioDynamics to be the exclusive U.S. distributor of Asclera, a polidocanol injection for spider and reticular veins. The deal replaces prior agreements, and Asclera showed 95% physician-rated success in a trial.